Cargando…
Humoral Responses Against Variants of Concern by COVID-19 mRNA Vaccines in Immunocompromised Patients
IMPORTANCE: There are limited comparative data on the durability of neutralizing antibody (nAb) responses elicited by messenger RNA (mRNA) vaccines against the SARS-CoV-2 variants of concern (VOCs) in immunocompromised patients and healthy controls. OBJECTIVE: To assess the humoral responses after v...
Autores principales: | Obeid, Michel, Suffiotti, Madeleine, Pellaton, Celine, Bouchaab, Hasna, Cairoli, Anne, Salvadé, Vanja, Stevenel, Caroline, Hottinger, Rosemary, Pythoud, Catherine, Coutechier, Lucie, Molinari, Laura, Trono, Didier, Ribi, Camillo, Gottardo, Raphael, Fenwick, Craig, Pascual, Manuel, Duchosal, Michel A., Peters, Solange, Pantaleo, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8914885/ https://www.ncbi.nlm.nih.gov/pubmed/35271706 http://dx.doi.org/10.1001/jamaoncol.2022.0446 |
Ejemplares similares
-
CXCL12 and CXCL13 Cytokine Serum Levels Are Associated with the Magnitude and the Quality of SARS-CoV-2 Humoral Responses
por: Noto, Alessandra, et al.
Publicado: (2022) -
(68)Ga-DOTATOC PET/CT to detect immune checkpoint inhibitor-related myocarditis
por: Boughdad, Sarah, et al.
Publicado: (2021) -
Restoration of NK Cell Cytotoxic Function With Elotuzumab and Daratumumab Promotes Elimination of Circulating Plasma Cells in Patients With SLE
por: Humbel, Morgane, et al.
Publicado: (2021) -
Response-adjusted regimen combining ruxolitinib, etoposide and dexamethasone (adRED) in adult patients with acute myeloid leukemia-associated hemophagocytic lymphohistiocytosis: a single-center pilot trial
por: Stalder, Grégoire, et al.
Publicado: (2022) -
Reactivation of IgA vasculitis after COVID-19 vaccination
por: Obeid, Michel, et al.
Publicado: (2021)